Gastroenterologist at @MayoClinic with expertise in the diagnosis and treatment of #IBD. Tweets are my own. #MayoClinicFL

Joined December 2015
2 Photos and videos
Francis (Frank) Farraye, MD, MSc retweeted
Thank you @DDS_Journal for highlighting our work on BAS & pouchitis @AlsakarnehSaqr @FarrayeIBD ✅BAS not inferior to abx in nonresponse or early relapse (aOR=0.94, p=0.34) ✅ BAS ⬇️ recurrent pouchitis (aHR: 0.57; p<0.001) and ⬆️ time to recurrent pouchitis (p<0.001)
Alsakarneh et al retrospectively studied the response of patients with pouchitis and resulting from IBD surgery, finding that treatment with bile acid sequestrants was noninferior or possibly superior to the current standard, antibiotic treatment. bit.ly/4mUEVoz
3
6
27
3,964
Francis (Frank) Farraye, MD, MSc retweeted
Our #IBD group is growing under @FarrayeIBD leadership Welcome Dr. John Gubatan @JGubatanMD joining @MayoClinicFLGIH family from Standford where he served as #IBD faculty
1
3
26
1,371
Francis (Frank) Farraye, MD, MSc retweeted
15 Aug 2025
Gaining the Upper Hand – Upadacitinib for Crohn’s Disease with Ileostomy: A Real-World Gap Addressed. rdcu.be/eARJX . My invited commentary on doi.org/10.1007/s10620-025-0…, just published in @DDS_Journal. @LaurenLoebMD @FarrayeIBD @EdwardLoftus2 @ibdgijami @JHashashMD

1
4
15
980
Francis (Frank) Farraye, MD, MSc retweeted
Join us for our 2nd @Mayoclinic #IBD Conference in ☀️🏖️ Florida 🐊 @MayoClinicFLGIH 📍Mayo FL 🗓️ Saturday, Nov 8 💻 Virtual option available ➕🩻 bonus Friday session with ✋🤚 on IUS session 📝👉 tinyurl.com/3emuhwpv @FarrayeIBD @ibdgijami @JGubatanMD @CrohnsColitisFn
1
15
63
4,593
Francis (Frank) Farraye, MD, MSc retweeted
11 Jun 2025
Such a pleasure to host Francis A. Farraye, MD, MSc, today for GI Grand Rounds as we celebrated our fourth annual Peppercorn Lectureship, named for Dr. Mark Peppercorn! We all enjoyed learning from Dr. Farraye's talk, "Health Maintenance for Patients with IBD." 🌟
1
2
17
1,433
Francis (Frank) Farraye, MD, MSc retweeted
Hot of the press 🚨 Just published in @APandT our study on risk of new onset #IBD in patients taking IL-17 inhibitors 💊 🔑 findings: 📌 Patients on anti-IL-17 are at increased risk of de novo IBD (aHR: 2.5) 📌 Risk was elevated for both UC and CD 📌Number needed to harm (NNH=161) 📌Secukinumab was associated with highest risk (aHR=2.82) Full 📖: onlinelibrary.wiley.com/doi/…@FarrayeIBD @JHashashMD @OmarAlTaanii @RazanAburummann @AmCollegeGastro @AmerGastroAssn @CrohnsColitisFn @ACPIMPhysicians @ACRheum #GITwitter #MedTwitter
3
6
36
7,480
Francis (Frank) Farraye, MD, MSc retweeted
11 Dec 2024
Incredibly high yield topic on everyday IBD in terms of things to monitor in patients with IBD! @DCharabaty @FarrayeIBD @PDulaiMD @IBDConference #AIBD2024
25
34
10,907
Francis (Frank) Farraye, MD, MSc retweeted
🔥New article published in @AmJGastro 📈 IBD incidence is surging disproportionately affecting females and the elderly ⬆️ 75% of countries report rising incidence rates shorturl.at/GL4pn @FarrayeIBD @KarnJUVE @Siew_C_Ng @RashidLui @GKochharMD @ChawinthornV @ttuhscmed
2
12
39
4,290
Francis (Frank) Farraye, MD, MSc retweeted
💡 Key Question: Are patients with IBD at higher risk for shingles complications? (Spoiler: Yes!) 📊 What We Found: IBD patients had 15.52% complication rate vs 12.51% in non-IBD controls (p<0.0001) 4/12 @IBDProNews @CrohnsColitisFn @FarrayeIBD
1
1
2
300
Francis (Frank) Farraye, MD, MSc retweeted
New Clinical Practice Update in @AGA_CGH by Drs. Anna M. Buchner, @MariettaIacucci, and @FarrayeIBD explores using endoscopic scoring systems for mucosal healing for patients with #IBD, including ulcerative colitis and #Crohn's disease. 🔗Learn more: ow.ly/WawU50U7b8W
9
16
2,500
Francis (Frank) Farraye, MD, MSc retweeted
#IBD patients want to know… What they can do in addition to starting effective medical therapy for their inflammation 🚭 avoid smoking 🍽️Diet: Mediterranean diet 🍆🥑🍓🥦 🚫NSAID 🎯Normal BMI 🏃🏽‍♀️Get active 😊Focus on mental health 👶Discuss contraception @AshwinMDIBD
2
10
20
3,233
Francis (Frank) Farraye, MD, MSc retweeted
Save the date!! Sept 28, 2024! For Updates in IBD conference @MayoClinic FL Great topics Amazing speakers Sun and Fun Sign up ce.mayo.edu/ibd2024 @AmCollegeGastro @AmerGastroAssn @CrohnsColitisFn @IBDProNews @FarrayeIBD @ibdgijami @EdwardLoftus2 @MLongMD @Khanna_S @IBDMD
20
85
7,694
Francis (Frank) Farraye, MD, MSc retweeted
Great work coming from the #IBD groups at @MayoClinicFLGIH @AHNGastro in collaboration in @APandT @akMD03 @JessPetrovMD @FarrayeIBD @JHashashMD @GKochharMD 🔥 topic #GLP1 in #IBD ➡️ no difference in steroid use but ⬇️ risk of surgery in #CD and #UC rb.gy/591zna
1
7
13
1,577
Francis (Frank) Farraye, MD, MSc retweeted
Join us for Mayo Clinic Updates in Inflammatory Bowel Disease 2024 Updates in the diagnosis management of #IBD & related complications Open to physicians, APPs, nurses, pharmacists, learners   Sept 28 7AM-6PM Mayo Clinic Florida Jacksonville, Florida   Visit ce.mayo.edu/ibd2024 for details and registration
1
3
9
2,124
Francis (Frank) Farraye, MD, MSc retweeted
2 Jul 2024
🔎 ACG Case Reports Journal 🔍 Sirolimus Use in Refractory Crohn's Disease Siu, et al. 👉 bit.ly/45Clnh7 @RSiuMD @ChristianKarime @JHashashMD @ibdgijami @FarrayeIBD @KhushbooSGala @VibhuC_MD #GIfellows
5
6
1,370
Excited to be returning to Boston to speak at the upcoming #BostonIBD conference about the latest advancements in #IBDResearch and treatment. Looking forward to connecting with faculty and attendees. Hope to see you there! cme.bu.edu/BostonIBD24 @BU_CME

2
1
10
1,055
Francis (Frank) Farraye, MD, MSc retweeted
Patients with Inflammatory Bowel Disease are at Increased Risk for Hospitalization due to RSV: Official journal of the American College of Gastroenterology | ACG journals.lww.com/ajg/abstrac… @Ryansmith_MD @FarrayeIBD @akMD03 @AmJGastro @ACG @CrohnsColitisFn @AmerGastroAssn

2
18
36
3,821